News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
126 Results
Type
Article (1)
Company Profile (1)
Press Release (124)
Section
Business (38)
Deals (4)
Drug Development (14)
FDA (2)
News (54)
Tag
Alliances (1)
Approvals (2)
Biotechnology (1)
Clinical research (6)
Compensation (2)
C-suite (1)
Data (3)
Duchenne muscular dystrophy (5)
Earnings (18)
Events (42)
Executive appointments (1)
FDA (3)
Healthcare (8)
IPO (4)
People (23)
Phase I (5)
Phase II (6)
Phase III (1)
Preclinical (8)
Startups (1)
Date
Last 30 days (2)
Last 365 days (32)
2025 (15)
2024 (31)
2023 (18)
2022 (19)
2021 (21)
2020 (15)
2019 (7)
Location
Massachusetts (32)
United States (32)
126 Results for "Dyne_tx".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Dyne Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
May 8, 2025
·
8 min read
Press Releases
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 14, 2025
April 15, 2025
·
2 min read
Press Releases
Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-251 in Duchenne Muscular Dystrophy
April 24, 2025
·
8 min read
Press Releases
Dyne Therapeutics Announces Chief Business Officer and Chief Scientific Officer Appointments
April 16, 2025
·
7 min read
Press Releases
Dyne Therapeutics to Present at Stifel 2025 Virtual CNS Forum
March 11, 2025
·
1 min read
Press Releases
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Financial Officer
March 21, 2025
·
2 min read
Press Releases
Dyne Therapeutics Announces Appointment of Erick J. Lucera as Chief Financial Officer
March 20, 2025
·
5 min read
Press Releases
Dyne Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 3, 2025
·
1 min read
Press Releases
Dyne Therapeutics Announces Upcoming Presentations at the 2025 MDA Clinical & Scientific Conference
February 17, 2025
·
5 min read
Press Releases
Dyne Therapeutics Announces New Long-Term Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating Unprecedented and Sustained Functional Improvement Through 18 Months
March 17, 2025
·
11 min read
1 of 13
Next
Otomatik - 108.157.60.45
CloudFlare DNS
Türk Telekom DNS
Google DNS
Open DNS
OSZAR »
